Metabolite details
Reactome pathways
- No Reactome pathways listed for this metabolite.
Observed in studies
- Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
- Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
- Microbial Diversity and Non-volatile Metabolites Profile of Low-Temperature Sausage Stored at Room Temperature
- Metabolic Responses of a Model Green Microalga Euglena gracilis to Different Environmental Stresses
- Transcriptional memory of dFOXO activation in youth curtails later-life mortality
- Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Feces metabolomics)
- Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
- Metabolic disorder and intestinal microflora dysbiosis in chronic inflammatory demyelinating polyradiculoneuropathy
- PatA mediates biofilm formation and drugs resistance through regulating the synthesis of glycolipids and lipids in mycobacterium PatA mediates a novel mycolic acid synthesis pathway and regulates biofilm formation in mycobacterium
- Unraveling the metabolic effects of benzophenone-3 on the endosymbiotic dinoflagellate Cladocopium goreaui
Observed in differential profiles
- G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
- G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
- G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
- Control_vs_Day_12
- Control_vs_Paramycin
- RU-_Control_vs_RU+_Switch
- Normal_vs_Neural_Tube_Defect
- Control_vs_ZYP_High_Dose
- CIDP_patient_vs_healthy_control
- CIDP_patient_vs_healthy_control
- wild_type_vs_patA_deletion
- Control_vs_BP3_Low_Concentration